| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
9e-07 |
| mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-06 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |